Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 224

    1.

    To filter blood or universal leukoreduction: what is the answer?

    Shapiro MJ.

    Crit Care. 2004;8 Suppl 2:S27-30. Epub 2004 Jun 14. Review.PMID: 15196319 [PubMed - indexed for MEDLINE]Related articles

    2.

    Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.

    King KE, Shirey RS, Thoman SK, Bensen-Kennedy D, Tanz WS, Ness PM.

    Transfusion. 2004 Jan;44(1):25-9.PMID: 14692963 [PubMed - indexed for MEDLINE]Related articles

    3.

    Leukoreduction of blood components.

    Dzik WH.

    Curr Opin Hematol. 2002 Nov;9(6):521-6. Review.PMID: 12394176 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Clinical applications of leukocyte filters]

    Bordin JO, Fabron Júnior A.

    Rev Assoc Med Bras. 1997 Jul-Sep;43(3):205-8. Review. Portuguese. PMID: 9497547 [PubMed - indexed for MEDLINE]Related articles

    5.

    The clinical benefits of the leukoreduction of blood products.

    Blajchman MA.

    J Trauma. 2006 Jun;60(6 Suppl):S83-90. Review.PMID: 16763486 [PubMed - indexed for MEDLINE]Related articles

    6.

    Transfusion in the intensive care unit.

    Vincent JL, Piagnerelli M.

    Crit Care Med. 2006 May;34(5 Suppl):S96-101. Review.PMID: 16617264 [PubMed - indexed for MEDLINE]Related articles

    7.

    HLA alloimmunization of surgical patients by transfusion with bedside leukoreduced blood components.

    Ohto H, Nomizu T, Kuroda F, Hoshi T, Rokkaku Y.

    Fukushima J Med Sci. 2003 Jun;49(1):45-54.PMID: 14603951 [PubMed - indexed for MEDLINE]Related articles

    8.

    Leukoreduction filtration of blood with sickle cell trait.

    Schuetz AN, Hillyer KL, Roback JD, Hillyer CD.

    Transfus Med Rev. 2004 Jul;18(3):168-76. Review.PMID: 15248166 [PubMed - indexed for MEDLINE]Related articles

    9.

    An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.

    Cervia JS, Sowemimo-Coker SO, Ortolano GA, Wilkins K, Schaffer J, Wortham ST.

    Transfus Med Rev. 2006 Jul;20(3):190-206. Review.PMID: 16787827 [PubMed - indexed for MEDLINE]Related articles

    10.

    Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.

    Cleemput I, Leys M, Ramaekers D, Bonneux L.

    Int J Technol Assess Health Care. 2006 Fall;22(4):403-7.PMID: 16984672 [PubMed - indexed for MEDLINE]Related articles

    11.

    Optimizing platelet transfusion therapy.

    Heal JM, Blumberg N.

    Blood Rev. 2004 Sep;18(3):149-65. Review.PMID: 15183900 [PubMed - indexed for MEDLINE]Related articles

    12.

    Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.

    Utter GH, Nathens AB, Lee TH, Reed WF, Owings JT, Nester TA, Busch MP.

    Transfusion. 2006 Nov;46(11):1863-9.PMID: 17076839 [PubMed - indexed for MEDLINE]Related articles

    13.

    Leukocyte-reduced blood components: patient benefits and practical applications.

    Higgins VL.

    Oncol Nurs Forum. 1996 May;23(4):659-67. Review.PMID: 8735324 [PubMed - indexed for MEDLINE]Related articles

    14.

    Universal pre-storage leukoreduction--A defensible use of hospital resources: the Yale-New Haven Hospital experience.

    Fisk JM, Snyder EL.

    Dev Biol (Basel). 2005;120:39-44.PMID: 16050154 [PubMed - indexed for MEDLINE]Related articles

    15.

    Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs.

    Lane TA.

    Arch Pathol Lab Med. 1994 Apr;118(4):392-404. Review.PMID: 8166589 [PubMed - indexed for MEDLINE]Related articles

    16.

    Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units.

    Hillyer CD, Emmens RK, Zago-Novaretti M, Berkman EM.

    Transfusion. 1994 Oct;34(10):929-34. Review. No abstract available. PMID: 7940668 [PubMed - indexed for MEDLINE]Related articles

    17.

    Universal leukocyte reduction: Is it appropriate medical practice or not?

    Angelbeck JH, Ortolano GA.

    J Infus Nurs. 2005 Jul-Aug;28(4):273-81. Review.PMID: 16106211 [PubMed - indexed for MEDLINE]Related articles

    18.

    Adverse effects of transfusions caused by leukocytes.

    Raife TJ.

    J Intraven Nurs. 1997 Sep-Oct;20(5):238-44.PMID: 9369624 [PubMed - indexed for MEDLINE]Related articles

    19.

    Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.

    Pruss A, Kalus U, Radtke H, Koscielny J, Baumann-Baretti B, Balzer D, Dörner T, Salama A, Kiesewetter H.

    Transfus Apher Sci. 2004 Feb;30(1):41-6.PMID: 14746820 [PubMed - indexed for MEDLINE]Related articles

    20.

    HLA antigens on leukocyte fragments and plasma proteins: prestorage leukoreduction by filtration.

    Dzik S, Szuflad P, Eaves S.

    Vox Sang. 1994;66(2):104-11.PMID: 8184591 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data